文献速递腹部泌尿生殖MR

肝胆期在EOB-MRI中预测肝癌高危患者非富血供低信号病灶富血供化转归的价值

The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2021-01-03

前瞻性纳入22例慢性病毒性肝炎高危患者的29个EOB-MRI动脉期非富血供、肝胆期低信号病灶,随访644(220-2912)天后20个病灶转为动脉期富血供。富血供化组的肝胆期病灶-肝实质信号强度比(增强后比值)在随访≥3次和4次时各时间点间存在差异,并随时间呈线性下降趋势;两组增强后比值在3次随访的终点及4次随访的第2、3次和终点有显著差异。结论提示肝胆期信号强度下降趋势可能早期预测不良的富血供化转归。

要点

  • EOB-MRI动脉期非富血供、肝胆期低信号的病灶中,肝胆期信号强度比值随时间下降可能提示富血供化。
  • 富血供化组肝胆期增强后比值在随访≥3次和4次时各时间点间有差异,呈线性下降趋势。
  • 两组增强后比值在3次随访终点及4次随访第2、3次和终点有显著差异,EOB增强比值仅3次随访终点有组间差异。

核心结论

  • 对于动脉期非富血供、肝胆期低信号的肝脏病灶,肝胆期信号强度下降趋势可能早期预测不良的富血供化转归。

研究设计与样本

  • 前瞻性研究,纳入22例慢性病毒性肝炎患者(中位年龄69岁,范围57-82岁)的29个新发病灶,病灶在EOB-MRI动脉期非富血供且肝胆期低信号。
  • 采用钆塞酸二钠增强MRI(EOB-MRI)连续随访,检查动脉期病灶血供、肝胆期病灶-肝实质信号强度比(增强后比值)及以平扫为参考的调整增强(EOB增强比值)。

关键影像表现/征象

  • 随访644(220-2912)天后,20个病灶在EOB-MRI动脉期转为富血供(富血供化组),9个维持非富血供(维持非富血供组)。
  • 富血供化组肝胆期增强后比值在随访≥3次(P < 0.01)和4次(P < 0.05)时各随访时间点间存在差异,并随时间呈线性下降趋势。
  • 两组增强后比值在3次随访的终点有显著差异(P < 0.001),在4次随访的第2次(P = 0.037)、第3次(P = 0.005)和终点(P = 0.005)有显著差异。
  • EOB增强比值仅在3次随访的终点显示组间差异(P = 0.008)。

诊断标准与关键数值

  • 病灶入选条件为EOB-MRI动脉期非富血供且肝胆期低信号。
  • 富血供化定义为随访中EOB-MRI动脉期出现富血供(hyperenhancement)。
  • 肝胆期信号强度比值为病灶-肝实质增强后比值,另计算以平扫为参考的EOB增强比值。

临床应用与阅片要点

  • 对高危患者动脉期非富血供、肝胆期低信号的病灶,随访中关注肝胆期信号强度比值的动态下降趋势。
  • 原文结论提示肝胆期信号强度下降趋势可能早期预测富血供化转归。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To estimate the role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI (EOB-MRI) in predicting hypervascularization outcome of non-hypervascular hypointense hepatic lesions in high-risk patients for hepatocellular carcinoma (HCC).

METHODS: Under the premise of non-hyperenhance in arterial phase (AP) and hypointensity in hepatobiliary phase (HBP) of EOB-MRI, 29 fresh lesions from 22 patients with chronic viral hepatitis (median (range) age: 69(57-82) years) were prospectively enrolled. During continuously followed-up by EOB-MRI, lesional vascularity in AP, the signal intensity (SI) ratios of lesions-to-parenchyma in HBP images (post-contrast ratio) and adjusted enhancement with reference of unenhanced images (EOB enhancement ratio) were examined.

RESULTS: After 644 (220-2912) days of follow-up, 20 lesions changed into hyperenhancement in AP of EOB-MRI (hypervascularized group), while nine remained non-hyperenhanced (maintained non-hypervascular group). There is no statistical difference of post-contrast ratio at the initial detection. The post-contrast ratios in hypervascularized group were different between each follow-up time point when followed-up ≥ three (P < 0.01) and four (P < 0.05) times, and exposed a linear downward trend with time. Between the hypervascularized and maintained non-hypervascular groups, there were significant differences in the post-contrast ratio at endpoint for three-times' follow-up (P < 0.001); and at the second (P = 0.037), third follow-up time points (P = 0.005), endpoint (P = 0.005) for four-times' follow-up. EOB enhancement ratio showed inter-group difference only at endpoint for three-times' follow-up (P = 0.008).

CONCLUSION: For non-hypervascular, HBP hypointense hepatic lesions, decreasing trend of SI in HBP may early predict unfavorable hypervascularized outcome.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wang F, Numata K, Chuma M, et al. The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma. Abdom Radiol (NY). 2021. PMID: 33388895. doi:10.1007/s00261-020-02881-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。